drexml:一个命令行工具和Python包用于药物重用
Marina Esteban-Medina1,2, Víctor Manuel de la Oliva Roque1,2, Sara Herráiz-Gil3,4,5,6
1Platform for Computational Medicine, Andalusian Public Foundation Progress and Health-FPS, Seville, Spain.
Computational and structural biotechnology journal
|March 21, 2024
概括
我们开发了drexml,这是一个数据驱动的药物重定向工具. 它使用机器学习和途径建模来寻找Fanconi贫血和家族黑色素瘤等疾病的药物标,帮助发现新的治疗方法.
科学领域:
- 计算生物学是一种计算生物学.
- 药理学 药理学是指药理学的学科.
- 生物信息学是一种生物信息学.
背景情况:
- 药物重新定位为发现新疗法提供了更快,更具成本效益的方法.
- 罕见疾病往往缺乏有针对性的治疗方法,需要创新的药物发现策略.
- 将机器学习与机械模型相结合,可以提高药物标识的精度.
研究的目的:
- 介绍drexml,这是一个新的计算工具,用于合理的,数据驱动的药物重新使用.
- 利用机器学习和信号传导建模来识别疾病调节药物标.
- 采用可解释性方法,在疾病生物学中将已识别的目标置于背景.
主要方法:
- 开发了drexml作为命令行工具和Python包.
- 应用机器学习算法用于目标预测.
- 集成的机械信号传导路径建模.
- 生物背景的综合可解释性工具.
主要成果:
- 在Fanconi贫血和家族黑色素瘤中验证了drexml,这两种罕见疾病.
- 成功预测了先前验证的用于Fanconi贫血的重定向药物.
- 确定了一组有前途的新药候选药物用于家族黑色素瘤调查.
结论:
- drexml为数据驱动的药物重用提供了一个强大的框架.
- 该工具在确定罕见疾病的治疗策略方面表现出有效性.
- drexml通过将药物点与疾病机制联系起来,促进发现潜在的治疗方法.
相关概念视频
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Structure-Activity Relationships and Drug Design
716
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
716
Prodrugs
2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.6K
Principles of Drug Action
6.0K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.0K
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Drug-Receptor Interactions
5.2K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.2K


